FDA Adverse Event Injury Summary report: N

GORE EXCLUDER AAA ENDOPROSTHESIS

MDR report key: 1972232 · Received January 21, 2011

Report

Report Number
2017233-2011-00035
Event Type
Injury
Date Received
January 21, 2011
Date of Event
January 20, 2011
Report Date
January 20, 2011
Manufacturer
W.L. GORE & ASSOCIATES
Product Code
MIH
PMA / PMN Number
P020004
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
IN, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

A REVIEW OF THE MANUFACTURING PAPERWORK HAS BEEN CONDUCTED. THE REVIEW OF THE MANUFACTURING PAPERWORK VERIFIED THAT THIS LOT MET ALL PRE-RELEASE SPECIFICATIONS. AS STATED IN THE GORE EXCLUDER AAA ENDOPROSTHESIS INSTRUCTIONS FOR USE, COMPLICATIONS THAT MAY OCCUR AND/OR REQUIRE INTERVENTION INCLUDE, BUT ARE NOT LIMITED TO, ENDOLEAK. ADD'L GORE DEVICES RELATED TO THIS EVENT: (B)(4).

Description of Event or Problem · 1

ON (B)(6) 2010, THE PT WAS IMPLANTED WITH THREE GORE EXCLUDER AAA ENDOPROSTHESES TO TREAT AN ABDOMINAL AORTIC ANEURYSM. IT WAS NOTED THAT THE PROXIMAL NECK ANGLE MEASURED ABOUT 70 DEGREES. A POSSIBLE TYPE-2 ENDOLEAK FROM THE LUMBAR ARTERIES WAS SUSPECTED UPON COMPLETION ANGIOGRAPHY. THE PT TOLERATED THE PROCEDURE WELL. ON (B)(6) 2011, A REINTERVENTION OCCURRED TO TREAT A PROXIMAL TYPE-1 ENDOLEAK WITH SLIGHT, INDETERMINATE ANEURYSM GROWTH. A GORE EXCLUDER AAA AORTIC EXTENDER ENDOPROSTHESIS WAS PLACED. FINAL ANGIOGRAPHY CONFIRMED A TYPE-2 ENDOLEAK FROM A LUMBAR ARTERY. THE PT TOLERATED THE PROCEDURE WELL.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 GORE EXCLUDER AAA ENDOPROSTHESIS MIH/SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT MIH W.L. GORE & ASSOCIATES WLG425 06833498

Patients

Seq Age Sex Outcome Treatment
1 83 YR Hospitalization| R LASIX| (B)(4)| ASPIRIN| ATENOLOL| THYROXINE| PRAVACHOL| COUMADIN| MEDAMUCIL| ACTONEL